Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.
Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M, Maxwell C, Palmisano J, Keaney JF Jr, Morrow JD, Vita JA.
Widlansky ME, et al. Among authors: vita ja.
Hypertension. 2003 Sep;42(3):310-5. doi: 10.1161/01.HYP.0000084603.93510.28. Epub 2003 Jul 21.
Hypertension. 2003.
PMID: 12874094
Clinical Trial.